Home > PS Ratio > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of TORRENT PHARMACEUTICALS is 8.69.

Share Price ₹2,690.5Apr 26,2024
Market Cap ₹91,044.8 Cr
Sales-TTM₹10,474.0 CrTTM-Consolidated Results
Price/Sales8.69xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of TORRENT PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of TORRENT PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹91,044.8 Cr] as on Apr 26,2024

(/) Sales [ ₹10,474.0 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 8.69x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay '8.69 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of TORRENT PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of TORRENT PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of TORRENT PHARMACEUTICALS


PS Ratio Performance Analysis for TORRENT PHARMACEUTICALS

- TORRENT PHARMACEUTICALS 's latest p/e ratio is 8.69x.

- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 4.97x.

- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 5.37x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 5.56x.

- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 4.2x.


How does TORRENT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
TORRENT PHARMACEUTICALS 10,474.08.6991,044.8
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.61360,920.0
CIPLA LTD25,350.24.49113,794.0
DR REDDYS LABORATORIES LTD27,212.53.83104,316.0
ZYDUS LIFESCIENCES LTD19,024.25.0195,380.9
DIVIS LABORATORIES LTD7,492.814.26106,860.0
MANKIND PHARMA LTD9,946.39.5494,869.4
LUPIN LTD19,480.13.7873,642.4
AUROBINDO PHARMA LTD27,894.72.3866,278.5
ABBOTT INDIA LTD5,753.49.5554,961.0
ALKEM LABORATORIES LTD12,634.44.6458,604.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TORRENT PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.38x
Max industry PS 14.26x
Median industry PS 5.01x
Average industry PS 6.71x



You may also like the below Video Courses